Searched for
CRESTOR TABLETS
MNC pharma companies: Time to take a re-look? 8 pharma stocks, 5 with an upside of up to 34%Some time back an MNC pharma firm announced the divestment of one of its businesses in India. Another sold one of its plants. Now, with the...- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...
- MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...
- Indian companies have made a comeback. Will MNCs be able to do it ? 7 MNC pharma stocks with upside potential of up to 21%While they still trade at premium valuations, they have not created wealth for shareholders. The fact is an age-old theory that just having...
- Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...
- Cadila Healthcare gains on USFDA nod for memory loss drugThe group now has 252 approvals and has so far filed over 350 ANDAs since the commencement of the filing process in FY 2003-04.
- Sun Pharma gets FDA nod for rosuvastatin calcium tabletsSun Pharma said: "One of its subsidiaries has received final approval from USFDA for its Abbreviated New Drug Application (ANDA) for generi...
- Aurobindo Pharma gets FDA nod for rosuvastatin calcium tabsAurobindo Pharma has received final approval from the US health regulator USFDA for rosuvastatin calcium tablets, used in lowering choleste...
- Glenmark gets FDA nod for rosuvastatin calcium tabletsQuoting IMS sales data for the 12 months to May 2016, Glenmark said Rosuvastatin calcium tablets achieved annual sales of around USD 6.78 b...
- Europe approves Biocon's Rosuvastatin Calcium tabletsThe approval in the regulated markets marks an important milestone in Biocon's small molecules strategy of forward integration from APIs.
- Biggest intra-day gain in 13 months after China allays currency fearsThe Sensex rose 568 points, or 2.47%, to settle at 23,554, with 27 out of the 30 stocks in the index ending in the green.
- China's yuan fix, Japan stimulus hopes boost sentiment, drive markets upA turnaround in sentiments helped the Indian market log its biggest intra-day gain in more than a year led by banking and metal stocks.
- Ranbaxy labs gets Health Canada nod for cholesterol lowering drugRanbaxy Labs said it has received approval from the Health Canada to manufacture & mkt its generic RAN-Rosuvastatin tablets used for loweri...
- Aurobindo gets USFDA's tentative nod for CrestorAurobindo Pharma said it has received tentative approval of the USFDA for the generic version of Crestor tablets used in the cardiovascular...
- AstraZeneca India announces CRESTOR tablets launchAstraZeneca India announced the launch of CRESTOR® (rosuvastatin) 5, 10, 20 and 40 mg tablets. CRESTOR® is indicated for use in the treatme...
Load More
